Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis
The tumor-intrinsic NOD-like receptor family, pyrin-domain-containing-3 (NLRP3) inflammasome, plays an important role in regulating immunosuppressive myeloid cell populations in the tumor microenvironment (TME). While prior studies have described the activation of this inflammasome in driving pro-tu...
Main Authors: | Balamayooran Theivanthiran, Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael Plebanek, Nicholas C. DeVito, Brent A. Hanks |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/19/4753 |
Similar Items
-
657 Characterization and therapeutic targeting of a tumor-associated tolerogenic DC subpopulation driven by SREBP2 and the mevalonate metabolic pathway
by: Fang Liu, et al.
Published: (2021-11-01) -
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
by: Nicholas C. DeVito, et al.
Published: (2021-05-01) -
Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
by: Sonia Missiroli, et al.
Published: (2021-05-01) -
Role of Porphyromonas gingivalis in the downregulation of NLRp3 inflammasome in periodontitis
by: Neelam Gavali, et al.
Published: (2022-01-01) -
Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01)